Omega Pharma have disclosed that the MBO by Couckinvest NV has succeeded in gaining over 99% of shares during the squeeze-out process.
The company reports that as of 10 February 2012 Couckinvest holds 99.26% of outstanding shares, permitting it to force the transfer of the remaining shares into its ownership. The Omega Pharma shares were delisted from NYSE/Euronext Brussels on 6 February.